Skip to main content
logo
Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.560
-0.070 (-4.29%)
At close: Aug 21, 2026, 4:00 PM EDT
1.580
+0.020 (1.28%)
After-hours: Aug 21, 2026, 7:50 PM EDT

Alzamend Neuro Balance Sheet

Millions USD. Fiscal year is May - Apr.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Cash & Equivalents
0.713.950.385.1414.06
Cash & Short-Term Investments
0.713.950.385.1414.06
Cash Growth
-82.00%950.04%-92.69%-63.45%628.97%
Prepaid Expenses
1.050.230.080.690.35
Total Current Assets
1.764.180.465.8414.41
Property, Plant & Equipment
0.310.430.180.080.1
Total Assets
2.084.60.635.9214.52

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Accounts Payable
1.350.632.932.871.16
Short-Term Debt
--0.3--
Other Current Liabilities
----0
Total Current Liabilities
1.350.633.232.871.16
Total Liabilities
1.350.633.232.871.16

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Common Stock
00000.01
Additional Paid-In Capital
68.0462.551.436257.42
Retained Earnings
-67.31-58.54-54.02-44.07-29.19
Comprehensive Income & Other
----14.88-14.88
Total Common Equity
0.733.97-2.593.0513.35
Shareholders' Equity
0.733.97-2.593.0513.35
Total Liabilities & Equity
2.084.60.635.9214.52

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Total Debt
--0.3--
Net Cash (Debt)
0.713.950.085.1414.06
Net Cash Growth
-82.00%5141.53%-98.53%-63.45%782.32%
Net Cash Per Share
0.218.761.0071.17213.10
Filing Date Shares Outstanding
4.792.90.090.070.07
Total Common Shares Outstanding
4.260.780.080.070.07
Working Capital
0.423.54-2.772.9713.25
Book Value Per Share
0.175.10-33.9442.41188.78
Tangible Book Value
0.733.97-2.593.0513.35
Tangible Book Value Per Share
0.175.10-33.9442.41188.78
SEC Filings: 10-K · 10-Q